ライフサイエンスコーパス: laboratory test

1 tential to be developed as an NHS accredited laboratory test.

2 the assessment of clinical presentation and laboratory tests.

3 mited guidance on appropriate diagnostic and laboratory tests.

4 electrocardiograms, procedures, and clinical laboratory tests.

5 S. purpuratus is affected by temperature in laboratory tests.

6 g to streptavidin, are used in many clinical laboratory tests.

7 hods for evaluating persistence are based on laboratory tests.

8 r potential health and climate benefits than laboratory tests.

9 scrotum was performed together with routine laboratory tests.

10 herapeutic antibodies interfere with several laboratory tests.

11 sis of brain echinococcosis was confirmed by laboratory tests.

12 mplement, or even replace, many conventional laboratory tests.

13 ns, biomarkers, and toxins by decentralizing laboratory tests.

14 y compromises the quality and reliability of laboratory tests.

15 events, vital signs, electrocardiogram, and laboratory tests.

16 almic examination, physical examination, and laboratory testing.

17 metagenomic NGS were confirmed by orthogonal laboratory testing.

18 d for virus inactivation and subsequent safe laboratory testing.

19 gold-standard laboratory testing.

20 dism are nonspecific, the diagnosis requires laboratory testing.

21 allei, is rapidly detected and identified by laboratory testing.

22 m to improve the reliability and accuracy of laboratory testing.

23 of Ebola virus (EBOV) disease (EVD) requires laboratory testing.

24 tics should be given based on the results of laboratory testing.

25 h electrocardiography, echocardiography, and laboratory testing.

26 care had a higher prevalence of recommended laboratory testing.

27 ld entirely circumvent the need for forensic laboratory testing.

28 ion to $2.1 million for strategies involving laboratory testing ($10 per test), depending on testing

29 Patients underwent a combination of laboratory testing, 18F-fluorodeoxyglucose positron emis

30 Northwell Health Laboratories tested 46 793 persons for SARS-CoV-2 from 4

31 ompleted a history, physical exam, screening laboratory tests, 7 functional scales, reference serolog

32 Although transitory, >2 laboratory test abnormalities occurred more frequently a

33 ing comorbidities, abnormal vital signs, and laboratory test abnormalities.

34 In line with the current trend of laboratory test accreditation to international standards

35 However, since no laboratory test accurately predicts response to desmopre

36 Appropriate follow-up laboratory testing across all time periods occurred in 2

37 usion: Discontinuing acetylcysteine based on laboratory testing after 12 hours of treatment is feasib

38 rdering of postoperative day 1 (POD 1) serum laboratory tests after elective colorectal surgery are c

39 (QMS) approach to systematically reestablish laboratory testing, after evaluating structural and func

40 2014 it was the fifth most commonly ordered laboratory test among Medicare Part B payments.

41 isparities in guideline-appropriate baseline laboratory testing and abnormal laboratory values.

42 von Willebrand factor (VWF) laboratory testing and full-length VWF gene sequencing w

43 ta from 2015, we evaluated HIV, HCV, and HBV laboratory testing and infection confirmation rates and

44 ogen detection is moderately correlated with laboratory testing and is advantageous in detecting path

45 research with a more integrated approach to laboratory testing and outbreak reporting is essential t

46 educed the proportion of newborns undergoing laboratory testing and receiving empirical antibiotic tr

47 most clinical labs, necessitating reference laboratory testing and thereby delaying the availability

48 Although 77 standard clinical laboratory tests and 263 plasma proteins could not accur

49 because of the atypical presentation, normal laboratory tests and absence of the typical symptoms suc

50 avoiding delayed diagnosis with unnecessary laboratory tests and detrimental treatments.

51 tudies showing a correlation between certain laboratory tests and diagnosis suggest an alternative me

52 Children with similar findings on laboratory tests and echocardiography may be treated bas

53 atients underwent assessment of multiple VWF laboratory tests and echocardiography.

54 Laboratory tests and flow cytometry gating analyses were

55 m) emissions were studied by measurements in laboratory tests and in use.

56 ninvasive studies, including biomarkers from laboratory tests and liver stiffness measured through el

57 electrocardiogram, and blood collection for laboratory tests and mavacamten plasma concentration.

58 After laboratory tests and model analysis to evaluate the sens

59 enital Zika virus infection was confirmed by laboratory tests and no controls had confirmed Zika viru

60 s that evaluated imaging tests compared with laboratory tests and other types of tests (17.0 vs 14.0

61 led method validation criteria for automated laboratory tests and proved similar irrespective of the

62 ermined based on daily clinical assessments, laboratory tests and ultrasound findings.

63 Among them, 479 (24.0%) were confirmed by laboratory testing, and 94 (4.7%) and 1422 (71.3%) remai

64 omplications is based on clinical suspicion, laboratory testing, and appropriate diagnostic imaging.

65 omplications is based on clinical suspicion, laboratory testing, and appropriate diagnostic imaging.

66 history, cognitive and physical examination, laboratory testing, and brain imaging.

67 At each visit, assessments, laboratory testing, and counseling were done.

68 hospitalisation, outpatient, pharmaceutical, laboratory testing, and primary care from 1 July 2007 to

69 indings from comprehensive skin examination, laboratory testing, and transvaginal ultrasonography.

70 and osteonecrosis) by clinical examination, laboratory tests, and echocardiography.

71 Safety was assessed by adverse events (AEs), laboratory tests, and electrocardiograms.

72 inical laboratory tests, cerebrospinal fluid laboratory tests, and electrocardiographs.

73 on of the cause rely on clinical evaluation, laboratory tests, and imaging studies.

74 nical prediction tools, risk stratification, laboratory tests, and imaging widely used for diagnosis

75 dside judgment, interpretation of additional laboratory tests, and initial stabilization, with practi

76 come and included assessment of vital signs, laboratory tests, and serial eye examinations.

77 on of each sub-component of cognitive exams, laboratory tests, and their associations with baseline c

78 orted for the introduction of new, expensive laboratory tests, and therefore warrant further explorat

79 We observed a low prevalence of recommended laboratory testing, antiviral therapy initiation, and li

80 Prion-specific assays used in clinical laboratory testing are currently limited to two options.

81 Routine postoperative serum laboratory tests are a part of many colorectal surgery o

82 Clinical laboratory tests are now being prescribed and made direc

83 Most often, various laboratory tests are used in the diagnosis and control o

84 holds the promise of complementing existing laboratory tests as a means of assessing hyperandrogenem

85 armacists prescribed medications and ordered laboratory tests as per their scope of practice to achie

86 PrEP programmes include the ability to order laboratory tests at the time of the clinical visit and t

87 This minireview provides an overview of laboratory tests available for Crimean-Congo hemorrhagic

88 ndividuals exhibiting symptoms often receive laboratory testing based on clinic-specific standards of

89 A laboratory test bed and new test procedure were used to

90 Outcomes included laboratory testing before MRA initiation and in the earl

91 Automation of laboratory tests, bioinformatic analysis of biological s

92 Five laboratories tested both clinical and contrived samples

93 Furthermore, we report an interference with laboratory testing by fluorescein in this patient and su

94 ties, few evaluations examine disparities in laboratory testing by race/ethnicity, age, sex, Medicaid

95 aditional plasma-based hemostasis-thrombosis laboratory testing, by assessing functional pathways of

96 he gold-standard diagnostic tool, antemortem laboratory testing can be performed to aid in the diagno

97 Data from routinely ordered laboratory tests can be used to monitor adherence to cli

98 ed in the reestablishment of 92% of baseline laboratory testing capacity.

99 ological examinations, vital signs, clinical laboratory tests, cerebrospinal fluid laboratory tests,

100 er utilization of services, including use of laboratory testing, certain imaging tests, and emergency

101 rmance data that will facilitate data-driven laboratory test choices for managing patient care during

102 Standardized core laboratory tests classified TAA etiology and measured ao

103 tween SARS-CoV-2 test results and 20 routine laboratory tests collected within a 2-day period around

104 Based on laboratory tests commonly performed in clinical practice

105 ents underwent clinical examination, routine laboratory tests (complete blood count, serum creatinine

106 Cephalic tetanus was initially suspected but laboratory testing confirmed botulism.

107 Laboratory test costs were CD4=$11 and VL=$33.

108 If true, laboratory testing could add value in quantifying prosth

109 We determined if routine laboratory tests could exclude anaplasmosis, improving P

110 (i) a reactive CSF Venereal Disease Research Laboratory test (CSF-VDRL), (ii) detection of T. pallidu

111 Laboratory test cutoff values were calculated based on r

112 when compared to temperatures encountered in laboratory test cycles.

113 For targeted laboratory tests, Daphnia magna was used as a prototype

114 of long-term failure in relation to routine laboratory test data is presented as a vital step in bri

115 Based on clinical microbiology laboratory testing data of cerebrospinal fluid, the expe

116 Laboratory tests defining iron deficiency, the recogniti

117 Whereas laboratory tests demonstrate rapid deterioration of the

118 Currently implemented laboratory tests developed >40 years ago either are not

119 f the patient care area and the logistics of laboratory testing, diagnostic imaging, and the removal

120 might review safety considerations for these laboratory testing/diagnostic activities that are novel

121 Community Health Index, enabling us to link laboratory tests, dispensed community prescriptions, Sco

122 cookstoves were smaller than predicted from laboratory tests due to the effects of real-world condit

123 mmonly used mechanical models developed from laboratory testing (e.g., critical-state soil mechanics

124 sessments included adverse event monitoring, laboratory tests, ECG, and psychiatric measures.

125 ry clinical evaluation, electrocardiography, laboratory test, echocardiography, cardiac MRI, and coro

126 Routine history, physical examination, laboratory testing, electrocardiography, and plain x-ray

127 rne and wound botulism patients confirmed by laboratory testing, epidemiologic link, or association w

128 s not known whether the benefits measured in laboratory tests extend to more ecologically valid situa

129 ved communities, and undergo routine monthly laboratory testing, facilitating a practical, unbiased,

130 Data on patient characteristics, laboratory tests, follow-up visits, and pre- and posttre

131 Clinical laboratories test for extended-spectrum beta-lactamases

132 f symptomatic disease and lack of a specific laboratory test for acute infection complicates diagnosi

133 The lack of an accurate laboratory test for early Lyme disease contributes to mi

134 o underwent both periodontal examination and laboratory test for STC was included.

135 A subset of blood samples (n = 1154) was laboratory tested for HRP2 by bead-based immunoassay and

136 To optimize utility of laboratory testing for Clostridiodes difficile infection

137 is of group A streptococcal pharyngitis, and laboratory testing for confirmation of Streptococcus pyo

138 and new diagnostics guide the application of laboratory testing for diagnosis of endocarditis.

139 disease (EVD) epidemic in West Africa, field laboratory testing for EVD has relied on complex, multi-

140 egal framework regulating the performance of laboratory testing for medical care purposes.

141 as hypertension and diabetes because formal laboratory testing for NCDs is not used during overseas

142 years improve the diagnostic performance of laboratory testing for pulmonary tuberculosis.

143 All clinical samples underwent laboratory testing for triglyceride level, total protein

144 nce from this study does not support monthly laboratory testing for use of standard doses of oral iso

145 tissue disease, nailfold capillaroscopy and laboratory tests for antinuclear antibodies (ANA) and AN

146 Laboratory tests for CDI vary in sensitivity and specifi

147 Laboratory tests for Clostridioides difficile infection

148 pulation of active persons who had undergone laboratory tests for hemoglobin AS (HbAS) and who were s

149 The performance and interpretation of laboratory tests for Zika virus (ZKV) continue to be eva

150 Results of laboratory tests for Zika virus and brain imaging result

151 The monitoring of this process through laboratory testing forms the foundation of public health

152 ata related to the venereal disease research laboratory test from 1940-1960.

153 s from a tertiary hospital, including >9.4 M laboratory tests from >530,000 patients, in addition to

154 (ART) initiation can be characterized using laboratory tests from surveillance.

155 n and therefore used vital signs and routine laboratory tests, had the greater case identification wi

156 In the era of biologics, laboratory tests have become essential to evaluate the i

157 Both the theoretical analysis and laboratory tests have demonstrated that the hydraulic co

158 tocols to establish traceability of clinical laboratory tests, have been established and continue to

159 Overall, 646 (33%) had any fungal-specific laboratory test: histoplasmosis antibody test (n = 349 [

160 The precision values for laboratory-tested HNO(3(g)) collections are +/-0.6 per m

161 he potential clinical utility of this common laboratory test in predicting mortality risk warrants fu

162 LD diagnosis was supported by laboratory testing in 82 cases, including positive resul

163 population-level data on ART utilization and laboratory testing in British Columbia (1996-2015), we d

164 CDI diagnosis involves laboratory testing in conjunction with clinical assessme

165 imely diagnosis relies on appropriate use of laboratory testing in susceptible patients.Methods: The

166 cificity in both point-of-care and reference laboratory testing in this population (maximum cycle thr

167 metabolomics, advanced imaging, and clinical laboratory tests in addition to family/medical history.

168 tal aggregate cost of the protocolized POD 1 laboratory tests in these years was $64,000 based on Med

169 level of clinical suspicion and specialised laboratory testing, in addition to culture, histopatholo

170 ient interviews, medical records review, and laboratory testing including mumps serology and RT-PCR.

171 We collected information regarding various laboratory tests including ESR, CBC with differential, D

172 ections relies on appropriate application of laboratory testing, including antigen testing, serologic

173 ed the absence of fever or jaundice, and the laboratory tests, including that for pancreatic enzymes,

174 Adding routine laboratory testing increased cost per infection prevente

175 se awareness campaigns, health services, and laboratory testing increased from $17.7 to $29.9 billion

176 Monitoring HIV treatment with laboratory testing introduces delays for providing appro

177 ct costs of hospitalization, physician fees, laboratory tests, invasive procedures, outpatient encoun

178 Current laboratory testing is insensitive in early infection, th

179 g a clinical diagnosis difficult; therefore, laboratory testing is needed to confirm the diagnosis.

180 To compare outputs, standardized laboratory testing is required.

181 rauma centers is common; time from injury to laboratory testing is therefore highly variable.

182 result of pyrethroid exposure often seen in laboratory tests is mosquito leg loss, a condition that

183 odel incorporating readily available routine laboratory tests is powerful in identifying breast cance

184 Laboratory testing isolated the outbreak strains from fl

185 vidual patient level and that the quality of laboratory testing may vary between countries.

186 ous health consequences from interference of laboratory tests, MD1003 cannot be recommended for treat

187 The hospitalist laboratory testing mean cost per day was $138 (median [I

188 od general health, measured through clinical laboratory tests, medical history, and physical examinat

189 Review of laboratory testing methods revealed a limitation in the

190 ally implicated in CSA, specimen collection, laboratory test modalities, and laboratory report constr

191 Other caveats of laboratory testing need to be considered, as sporadic, g

192 A standard laboratory test of visual stress (the Pattern Glare Test

193 Laboratory testing of a virus isolated from the lesion c

194 ssible; in addition to clinical examination, laboratory tests of biopsied wound tissue are required f

195 Routine laboratory tests of hemostasis are unable to reflect the

196 Clinical laboratory tests of thyroid function (including serum co

197 Laboratory tests of tissue product from the donor, inclu

198 ake provisional PEP recommendations prior to laboratory testing or dog quarantine results.

199 Data do not support performing routine laboratory tests or imaging tests in asymptomatic patien

200 , these sediment samples were incubated with laboratory test organisms, and they exhibited variable t

201 Manufacturers of FDA-approved laboratory tests paid $12.9 million to professionals in

202 esults from paired glucose meter and central laboratory tests performed within 60 minutes of each oth

203 rediction, primary and secondary prevention, laboratory testing, physical activity, and nutrition.

204 Routine laboratory tests, physical examination and echocardiogra

205 Laboratory testing plays an important role in the diagno

206 No laboratory tests predict DHF or DSS.

207 alpha-diversity from ~1,000 blood analytes (laboratory tests, proteomics and metabolomics) in a coho

208 with a 28% reduced likelihood of a positive laboratory test result for SARS-CoV-2 confirmed by rever

209 with a 52% reduced likelihood of a positive laboratory test result for SARS-CoV-2 in African America

210 This retrospective analysis reviewed laboratory test results and food allergy histories (obta

211 portal use (communicating by email, viewing laboratory test results and information, and obtaining m

212 ion (median, 8 d), and clinical information, laboratory test results and patient outcomes were collec

213 Laboratory test results and pregnancy outcomes were eval

214 ation on diagnoses, dispensation claims, and laboratory test results for all citizens in the Stockhol

215 sible approach to wait for genetic and other laboratory test results so that clinically stable patien

216 reference intervals are essential when using laboratory test results to guide medical decisions.

217 Laboratory test results were also similar between genoty

218 Basic laboratory test results were crucial to prediction model

219 Laboratory test results were normal, with no evidence of

220 Laboratory test results were not affected by 0.1% deterg

221 Laboratory test results were unremarkable.

222 (medical history, physical examination, and laboratory test results), and the results of follow-up i

223 e status of 0-2, adequate organ function and laboratory test results, a life expectancy of at least 1

224 record included medications, comorbidities, laboratory test results, and demographics, among others.

225 ion, and those with extreme abnormalities in laboratory test results, are often identified at present

226 res among individuals at risk, we collected, laboratory test results, blood pressure, demographic, co

227 The patient's clinical examination findings; laboratory test results, including complete blood count;

228 The patient's clinical examination findings; laboratory test results, including complete blood count;

229 aufen analyses were compared to conventional laboratory test results, that is, BK viremia (quantitati

230 ld be accelerated by the timely reporting of laboratory test results.

231 cal Modification codes or positive influenza laboratory test results.

232 dverse events, injection site reactions, and laboratory test results.

233 Temporal inference from laboratory testing results and triangulation with clinic

234 The remaining 216 cases had negative laboratory testing results.

235 Laboratory tests revealed a serum alkaline phosphatase l

236 Laboratory tests revealed an increased C-reactive protei

237 Laboratory tests revealed elevated liver transaminase an

238 Laboratory tests, road tunnel and roadside experiments h

239 Protocolized POD 1 laboratory testing should be replaced with clinically-ba

240 Admission laboratory tests showed elevated diastase levels indicat

241 Assessments included laboratory tests, sociodemographic data, personal and tr

242 ting, like that established for conventional laboratory tests such as PCR, for bioinformatics pipelin

243 DTC spending on advertising for laboratory tests (such as genetic testing) increased fro

244 picture and can be confirmed with results of laboratory testing, such as serologic tests or polymeras

245 Simpler tools not requiring laboratory tests, such as the Fuster-BEWAT (blood pressu

246 ory and ophthalmic examination with selected laboratory testing targeted by clues from the history an

247 Each of the five laboratories tested the 40-isolate (20 unique isolates,

248 to shape public and clinician beliefs about laboratory testing, the benefits and harms of prescripti

249 By combining behavioural counselling and laboratory testing, the Men's Health Screening Program h

250 th the Guillain-Barre syndrome who underwent laboratory testing, the presence of ZIKV infection was s

251 In laboratory testing, the system consistently produces eff

252 Safety was checked every 2 wk by laboratory tests, the prostate-specific antigen response

253 with influenza-like illness are swabbed for laboratory testing; those testing positive for influenza

254 nee, peer navigation, RIC posters/brochures, laboratory test timing, flexible scheduling, appointment

255 /trainee, navigation, RIC posters/brochures, laboratory test timing, flexible scheduling, appointment

256 nsitivity but remains the most commonly used laboratory test to diagnose pulmonary tuberculosis (TB).

257 y there was scant data on the performance of laboratory testing to detect mecC-mediated beta-lactam r

258 iews of certain aspects of clinical mycology laboratory testing to provide a broader context for the

259 with clinical symptoms, exposure history and laboratory testing to rapidly diagnose patients who are

260 and illustrate how we use commonly available laboratory tests to assess iron status during routine pa

261 currently no well-established biomarkers or laboratory tests to diagnose ME/CFS.

262 The performance of laboratory tests to diagnose pulmonary tuberculosis is d

263 ailable evidence does not support the use of laboratory tests to guide the dose of aspirin or clopido

264 Patients underwent baseline laboratory testing, total erythrocyte protoporphyrin (eP

265 Costs of laboratory testing, treatment, and hearing loss were dra

266 equires a combination of case definition and laboratory tests, typically real-time reverse transcript

267 ya virus (CHIKV) or viral RNA is the primary laboratory test used to diagnose infection in serum coll

268 t adult medical literature excluding routine laboratory tests using MEDLINE, EMBASE, and Web of Scien

269 logists can use electronic tools to optimize laboratory test utilization in their health care system.

270 Optimal laboratory test utilization is important for providing h

271 sts have long been advocates for appropriate laboratory test utilization, the widespread availability

272 Uveitis specialists have a high rate of laboratory testing utilization in their evaluation of ne

273 ic characteristics, comorbidity markers, and laboratory test values.

274 or a reactive CSF-Venereal Disease Research Laboratory test (VDRL).

275 L, or reactive CSF Venereal Disease Research Laboratory test (VDRL).

276 ures included adverse events (AEs), clinical laboratory tests, vital signs, electrocardiograms, and v

277 istancing and masks, and further to 151 when laboratory testing was added among asymptomatic persons

278 Adverse reactions were recorded, and laboratory testing was performed during infusion and at

279 Laboratory testing was performed for Clostridium botulin

280 After obtaining samples, extensive laboratory testing was performed, including serologic an

281 Information on clinical characteristics and laboratory tests was obtained from each subject.

282 Costs associated with protocolized laboratory testing were calculated using dollar amounts

283 of diagnosis, clinical characteristics, and laboratory testing were collected from patient charts.

284 n Controlled Transient Elastography (TE) and laboratory tests were acquired in all patients.

285 In this paper, both field and laboratory tests were carried out to evaluate the long-t

286 In the past, laboratory tests were considered of limited value in Cro

287 Laboratory tests were performed at the time of admission

288 Laboratory tests were performed at time T0 (beginning of

289 e, general and oral clinical examination and laboratory tests were performed.

290 uated at baseline and weeks 3, 6, and 12 and laboratory tests were performed; 16S ribosomal RNA gene

291 and abnormalities in diagnostic imaging and laboratory tests were registered for QFT-G-positive pati

292 Laboratory tests were remarkable for leukocytosis.

293 easures of toxicity determined in short-term laboratory tests which are designed to reduce variabilit

294 nificant change in the mean value of several laboratory tests (white blood cell count and hepatic and

295 In a laboratory test with distinct (15)NO abundances, the ove

296 on of a mining rock drainage was observed in laboratory tests with acceptable repeatability and a coe

297 Simulations of common laboratory tests with increasing proportions of abnormal

298 07 as a low-cost alternative to conventional laboratory testing, with the goal of improving accessibi

299 ptimized all aspects of the CHAMPS molecular laboratory testing workflow including nucleic acid extra

300 Routine laboratory testing would prevent 96% of infections and r